mycoplasma
bovi
import
caus
pneumonia
otiti
media
arthriti
young
dairi
calv
critic
need
improv
prevent
strategi
pathogen
conduct
random
placebocontrol
doubleblind
field
trial
determin
efficaci
commerci
bovi
vaccin
prevent
bovisassoci
diseas
calv
calv
n
florida
dairi
histori
bovi
infect
receiv
bovi
bacterin
placebo
administ
subcutan
day
age
one
herd
experi
bovisassoci
diseas
calv
remain
herd
incid
risk
respiratori
diseas
otiti
media
arthriti
day
age
respect
vaccin
effect
age
first
treatment
bovisassoci
diseas
incid
respiratori
diseas
mortal
weight
gain
nasal
colon
bovi
first
day
life
one
herd
vaccin
associ
increas
risk
otiti
media
associ
bovisspecif
serum
antibodi
titer
morbid
vaccin
calv
field
condit
studi
vaccin
efficaci
prevent
bovisassoci
diseas
young
dairi
calv
mycoplasma
bovi
signific
worldwid
pathogen
adult
dairi
cow
well
intens
rear
beef
dairi
calv
past
decad
bovi
emerg
increasingli
import
caus
respiratori
diseas
otiti
media
arthriti
young
calv
less
month
age
clinic
diseas
caus
bovi
tend
chronic
debilit
unrespons
antimicrobi
therapi
diseas
outbreak
high
morbid
rate
occur
econom
devast
affect
farm
cost
infect
primarili
associ
intens
treatment
affect
calv
coupl
cull
anim
unrespons
therapi
bovisassoci
diseas
also
import
anim
welfar
perspect
often
result
calv
subject
sever
chronic
ill
produc
veterinarian
provid
limit
relief
therefor
critic
need
develop
improv
prevent
treatment
strategi
bovisassoci
diseas
current
control
bovi
infect
calv
focus
remov
identifi
potenti
risk
factor
colon
upper
respiratori
tract
calv
bovi
often
occur
within
first
week
life
result
feed
milk
cow
infect
bovi
probabl
direct
indirect
transmiss
calv
shed
bovi
nasal
secret
remov
infect
milk
diet
pasteur
feed
milk
replac
success
appli
reduc
infect
break
pasteur
associ
subsequ
infect
outbreak
manag
practic
reduc
stock
densiti
improv
ventil
exampl
chang
reduc
undifferenti
respiratori
diseas
hous
calv
recommend
bovi
control
similarli
control
pathogen
involv
bovin
respiratori
diseas
complex
like
reduc
bovi
infect
manag
techniqu
improv
gener
immun
function
improv
nutrit
statu
minim
environment
stress
also
suggest
benefici
vaccin
potenti
strategi
control
bovi
infect
effort
develop
efficaci
vaccin
bovi
use
young
calv
problemat
vaccin
bovi
afford
protect
respiratori
diseas
european
field
trial
vaccin
efficaci
respiratori
diseas
arthriti
experiment
challeng
studi
howev
case
vaccin
bovi
significantli
exacerb
clinic
diseas
addit
experiment
challeng
studi
perform
calv
substanti
older
age
natur
colon
bovi
typic
first
observ
young
calv
often
colon
bovi
within
first
week
life
time
immun
system
undergo
rapid
chang
associ
matur
therefor
agespecif
featur
immun
system
like
import
determin
suscept
young
calf
mycoplasm
diseas
efficaci
particular
vaccin
sever
bacterinbas
vaccin
bovi
current
market
us
well
number
compani
manufactur
autogen
bovi
bacterin
howev
commerci
vaccin
licens
use
young
dairi
calf
best
author
knowledg
independ
studi
publish
efficaci
pauciti
studi
critic
evalu
current
market
bovi
vaccin
autogen
bacterin
welldesign
independ
efficaci
studi
appropri
age
group
major
gap
understand
potenti
current
avail
vaccin
manag
strategi
control
bovi
infect
young
calv
part
address
gap
conduct
field
trial
use
commerci
bovi
bacterin
approv
use
feeder
stocker
calv
object
field
trial
determin
efficaci
commerci
produc
bovi
bacterin
prevent
bovisassoci
diseas
respiratori
diseas
otiti
media
arthriti
mortal
dairi
calv
day
age
addit
object
compar
vaccin
placebotr
calv
respect
weight
gain
birth
day
age
rate
nasal
colon
bovi
bovisspecif
serum
immunoglobulin
ig
concentr
studi
holstein
heifer
three
florida
herd
use
random
field
trial
design
refer
popul
studi
heifer
calv
florida
dairi
herd
endem
bovi
infect
studi
unit
holstein
heifer
calf
cluster
one
three
herd
northcentr
florida
herd
select
base
willing
particip
histori
mycoplasmaassoci
diseas
calv
accord
calf
health
record
least
calv
treat
respiratori
diseas
otiti
media
andor
arthriti
year
preced
studi
calv
enrol
march
decemb
herd
approxim
lactat
cow
calv
bed
sand
individu
hutch
place
approxim
apart
opensid
barn
mechan
ventil
calv
fed
unpasteur
bulk
tank
milk
calv
receiv
modifi
live
viru
mlv
intranas
vaccin
parainfluenza
viru
type
pi
viru
infecti
bovin
rhinotrach
viru
ibr
first
week
life
intramuscular
mlv
vaccin
ibr
pi
bovin
respiratori
syncyti
viru
brsv
bovin
viral
diarrhea
viru
bvdv
type
administ
week
age
clostridi
vaccin
administ
week
age
calv
wean
approxim
week
age
turn
group
pen
approxim
week
age
herd
b
approxim
lactat
cow
major
calv
hous
individu
elev
metal
crate
concretefloor
opensid
barn
mechan
ventil
small
proport
calv
hous
individu
hutch
grass
calv
hous
metal
crate
nosetonos
contact
neighbor
calv
feed
protocol
vari
studi
period
includ
milk
replac
unpasteur
pasteur
wast
milk
vaccin
protocol
similar
describ
herd
calv
wean
week
age
turn
group
pen
week
age
herd
c
approxim
lactat
cow
calv
hous
grass
individu
hutch
place
least
apart
calv
primarili
fed
pasteur
wast
milk
supplement
milk
replac
necessari
sever
failur
pasteur
document
studi
period
cultur
milk
follow
pasteur
calv
receiv
oral
bolu
contain
antibodi
bovin
coronaviru
escherichia
coli
time
colostrum
feed
first
defens
portland
vaccin
protocol
mlv
intranas
pi
ibr
clostridi
vaccin
similar
describ
herd
except
intramuscular
mlv
vaccin
pi
ibr
bvdv
type
brsv
administ
week
age
calv
wean
week
age
turn
group
pen
week
age
holstein
heifer
calv
born
studi
period
consid
healthi
produc
day
age
enrol
studi
calv
assign
one
two
group
base
eartag
number
odd
number
assign
one
group
even
number
group
assign
odd
even
number
group
decid
per
farm
basi
coin
flip
one
group
receiv
ml
dose
kill
singl
strain
bovi
bacterin
proprietari
oilbas
adjuv
condit
licens
prevent
respiratori
diseas
us
feeder
stocker
calv
time
studi
texa
vet
lab
inc
san
angelo
tx
group
receiv
placebo
vaccin
compon
except
antigen
control
group
vaccin
placebo
administ
subcutan
neck
day
age
ml
dose
administ
day
age
second
third
dose
administ
calv
sick
howev
calf
recov
within
day
dose
administ
week
due
date
calv
fail
recov
within
day
remain
studi
miss
dose
miss
dose
record
bacterin
placebo
prepar
blind
vaccin
manufactur
investig
farm
personnel
blind
throughout
data
collect
analysi
data
record
calf
includ
date
birth
eartag
number
group
alloc
date
vaccineplacebo
administr
miss
dose
vaccineplacebo
date
wean
date
administr
prevent
treatment
vaccin
record
calf
primari
outcom
interest
treatment
respiratori
diseas
otiti
media
arthriti
well
mortal
attribut
diseas
calv
follow
day
day
age
time
treatment
clinic
diseas
record
farm
personnel
use
standard
case
definit
farm
personnel
train
investig
follow
standard
protocol
health
assess
prepar
veterinarian
respiratori
diseas
defin
fever
rectal
temperatur
f
plu
increas
respiratori
rate
effort
andor
cough
andor
nasal
discharg
otiti
mediainterna
defin
ear
droop
andor
evid
ear
pain
head
shake
scratch
rub
ear
arthriti
defin
lame
pain
swell
joint
sick
calv
treat
per
normal
farm
protocol
clinic
ill
calf
farm
personnel
record
type
dose
antimicrobi
date
treatment
reason
treatment
whenev
calf
die
farm
personnel
record
caus
death
obviou
case
caus
death
verifi
field
necropsi
perform
investig
studi
personnel
visit
dairi
least
week
collect
calf
health
data
monitor
complianc
collect
sampl
passiv
transfer
colostr
immunoglobulin
influenc
immun
respons
vaccin
infecti
agent
blood
collect
calv
day
age
measur
total
serum
protein
concentr
subset
calv
herd
n
b
n
studi
intens
calv
weigh
birth
approxim
day
age
weight
gain
birth
day
express
kgday
nasal
swab
blood
sampl
collect
weekli
week
age
day
age
prior
collect
nasal
swab
gross
debri
wipe
extern
nare
use
steril
gauz
steril
rayontip
swab
polyurethan
plastic
shaft
bbl
tm
cultureswab
tm
liquid
stuart
medium
bd
franklin
lake
nj
insert
ventral
nasal
meatu
depth
approxim
swab
cultur
detect
nasal
colon
bovi
serum
analyz
bovisspecif
iga
igm
igg
igg
enzymelink
immunosorb
assay
elisa
swab
kept
ice
transport
process
within
h
collect
swab
use
streak
surfac
modifi
frey
agar
mycoplasma
cultur
perform
modifi
frey
broth
agar
medium
contain
wtvol
mycoplasma
broth
base
frey
bd
diagnost
system
spark
md
wtvol
dna
her
sperm
volvol
hors
serum
volvol
fresh
yeast
extract
wtvol
glucos
supplement
ul
penicillin
g
polymixin
b
mgl
cefoperazon
final
ph
adjust
plate
incub
c
co
examin
day
mycoplasm
growth
coloni
typic
bovi
morpholog
plug
broth
incub
c
h
store
c
could
confirm
bovi
polymeras
chain
reaction
pcr
prepar
sampl
pcr
l
broth
cultur
thaw
room
temperatur
pellet
centrifug
rpm
c
h
pellet
resuspend
l
lysi
buffer
mm
tri
hydroxymethyl
aminomethan
ph
volvol
tween
mm
dithiothreitol
sampl
incub
c
min
cool
c
l
clarifi
sampl
use
dna
templat
pcr
posit
control
broth
inocul
bovi
type
strain
process
nasal
isol
steril
water
use
neg
control
templat
bovi
identifi
pcr
housekeep
gene
uvrc
previous
describ
pcr
product
analyz
electrophoresi
v
h
agaros
gel
visual
stain
ethidium
bromid
blood
sampl
allow
clot
collect
serum
harvest
centrifug
store
c
wholecel
lysat
antigen
prepar
l
cultur
bovi
type
strain
grown
c
modifi
frey
broth
protein
concentr
determin
use
colorimetr
assay
biorad
hercul
ca
adjust
gml
antigen
store
aliquot
c
thaw
room
temperatur
requir
elisa
procedur
optim
use
standard
methodolog
microtit
plate
maxisorb
nunc
kamstrup
denmark
coat
g
per
well
antigen
sodium
phosphat
buffer
ph
contain
nacl
wtvol
nan
pbsa
incub
overnight
c
plate
wash
three
time
pbsa
contain
volvol
tween
pbst
use
autom
plate
washer
auto
plate
washer
biotek
instrument
inc
winooski
vt
block
l
per
well
block
buffer
pbst
contain
wtvol
egg
albumin
store
c
minimum
h
need
sera
dilut
igg
assay
igm
igg
assay
iga
assay
block
buffer
l
dilut
serum
ad
duplic
well
plate
incub
room
temperatur
h
plate
wash
describ
l
goat
antibovin
isotyp
conjug
alkalin
phosphatas
bethyl
laboratori
inc
montgomeri
tx
dilut
block
buffer
ad
well
plate
incub
room
temperatur
h
wash
describ
l
wtvol
pnitrophenol
phosphat
ad
well
plate
incub
dark
room
temperatur
h
optic
densiti
od
well
read
wavelength
nm
use
autom
plate
reader
ultra
micropl
reader
biotek
instrument
inc
winooski
vt
microtit
plate
blank
mean
valu
two
well
coat
antigen
incub
conjug
secondari
antibodi
substrat
blank
od
valu
subtract
sampl
well
mean
valu
pair
duplic
test
calcul
pool
sera
calv
natur
occur
mycoplasm
diseas
high
bovisspecif
titer
includ
plate
posit
control
neg
control
pool
serum
collect
calv
prior
ingest
first
colostrum
meal
cutoff
posit
result
averag
od
valu
minu
blank
neg
control
sera
plu
two
standard
deviat
establish
ten
assay
run
elisa
data
report
averag
od
valu
standard
serum
dilut
isotyp
withinbatch
betweenbatch
assay
variabl
assess
use
youden
plot
graphic
method
elisa
valu
obtain
lowest
middl
highest
dilut
control
serum
includ
plate
use
establish
target
valu
control
limit
use
monitor
consist
assay
ten
batch
valu
obtain
begin
seri
assay
plot
valu
obtain
standard
end
seri
valu
pool
sera
deviat
target
valu
assay
repeat
standard
field
necropsi
perform
studi
veterinarian
calv
die
euthan
select
calv
necropsi
caus
death
obviou
clinic
evid
bovi
infect
eg
leg
fractur
necessit
euthanasia
calv
examin
determin
caus
death
specif
determin
involv
bovisassoci
patholog
case
defin
bovisassoci
mortal
histori
respiratori
diseas
otiti
media
andor
arthriti
bovi
without
pathogen
isol
site
patholog
observ
patholog
consist
mycoplasm
diseas
necropsi
includ
collect
swab
palatin
tonsil
tympan
bulla
primari
bronchi
mycoplasm
cultur
addit
anim
previous
diagnos
respiratori
diseas
arthriti
otiti
media
macroscop
lung
patholog
observ
appropri
sampl
collect
lesion
site
determin
involv
bovi
well
viral
bacteri
respiratori
pathogen
sampl
collect
deem
necessari
determin
caus
death
veterinarian
perform
necropsi
swab
fresh
tissu
sampl
transport
ice
laboratori
soon
possibl
process
within
h
collect
tissu
sampl
fixat
collect
place
contain
buffer
formalin
submit
diagnost
patholog
servic
colleg
veterinari
medicin
univers
florida
sampl
embed
paraffin
section
stain
hematoxylin
eosin
histopatholog
read
diagnost
pathologist
without
knowledg
experiment
treatment
group
addit
cultur
mycoplasma
describ
nasal
swab
swab
aerob
microbiolog
cultur
process
isol
identifi
use
routin
clinic
bacteriolog
method
method
focus
identifi
bacteri
pathogen
respiratori
tract
mycoplasma
particularli
arcanobacterium
pyogen
histophilu
somni
mannheimia
haemolytica
pasteurella
multocida
well
pathogen
may
caus
septicemia
associ
sequela
young
calv
addit
diagnost
test
perform
request
veterinarian
conduct
necropsi
base
presumpt
diagnosi
macroscop
patholog
sampl
submit
florida
state
diagnost
laboratori
kissimme
fl
detect
bovin
respiratori
virus
indic
morbid
due
bovi
major
outcom
interest
therefor
use
calcul
sampl
size
time
studi
initi
health
record
indic
incid
respiratori
diseas
otiti
media
andor
arthriti
studi
herd
least
hypothes
reduct
incid
would
biolog
econom
signific
use
valu
togeth
confid
power
take
consider
attrit
rate
approxim
calcul
sampl
size
calv
per
group
secondari
outcom
interest
subset
calv
herd
b
hypothes
reduct
nasal
colon
rate
would
biolog
signific
use
valu
togeth
paramet
outlin
calcul
sampl
size
calv
per
group
calv
exclud
analys
clinic
sign
refer
organ
system
occur
concurr
respiratori
diseas
otiti
media
arthriti
except
diarrhea
without
fever
less
day
durat
incid
risk
rate
calcul
number
calv
treat
diseas
interest
divid
initi
number
calv
less
half
calv
die
studi
reason
diseas
interest
categor
outcom
variabl
incid
clinic
diseas
incid
mortal
incid
miss
dose
vaccineplacebo
cumul
risk
nasal
colon
compar
among
group
use
chisquar
test
data
analyz
effect
herd
passiv
transfer
statu
stratifi
mantelhaenszel
analysi
expect
count
cell
less
fisher
exact
test
use
quantit
outcom
variabl
postcolostr
total
serum
protein
concentr
gdl
age
first
treatment
clinic
diseas
day
averag
daili
weight
gain
birth
day
age
kgday
compar
among
group
use
independ
sampl
ttest
elisa
data
analyz
use
repeat
measur
anova
relationship
averag
daili
weight
gain
serolog
data
postcolostr
elisa
data
week
elisa
data
examin
use
pearson
correl
analys
p
valu
consid
signific
analys
perform
use
commerci
statist
softwar
spss
spss
inc
chicago
il
three
hundr
twentyeight
calv
herd
b
c
calv
respect
enrol
elig
inclus
studi
tabl
despit
histori
bovi
infect
herd
experi
bovisassoci
diseas
herd
b
one
calf
exclud
concurr
diseas
one
calf
exclud
dose
vaccineplacebo
inadvert
miss
herd
c
one
calf
exclud
concurr
diseas
one
calf
exclud
receiv
dose
vaccineplacebo
wrong
group
studi
therefor
exclud
analys
data
herd
includ
relev
incid
risk
clinic
respiratori
diseas
otiti
media
arthriti
assess
day
age
tabl
bovisassoci
respiratori
diseas
otiti
media
major
contributor
calf
diseas
herd
b
c
eight
case
arthriti
observ
herd
b
none
observ
herd
c
herd
much
lower
overal
mortal
risk
herd
b
c
bovisassoci
mortal
herd
b
account
major
mortal
risk
vs
overal
vaccin
control
group
equival
level
postcolostr
total
serum
protein
small
percentag
calv
receiv
second
vaccineplacebo
due
ill
differ
group
although
signific
differ
calv
miss
third
vaccineplacebo
data
herd
b
c
combin
vaccin
vs
control
control
calv
herd
b
miss
third
placebo
compar
vaccin
calv
miss
third
vaccin
p
vaccin
efficaci
limit
bovisassoci
morbid
young
dairi
calv
field
trial
vaccin
influenc
age
first
treatment
either
otiti
media
respiratori
diseas
overal
age
first
treatment
otiti
media
day
vaccin
calv
day
control
anim
calv
herd
c
treat
otiti
day
vaccin
day
control
wherea
treatment
later
age
herd
b
day
day
vaccin
control
calv
respect
similar
pattern
observ
respiratori
diseas
differ
overal
age
first
treatment
vaccin
control
calv
day
vaccin
day
control
otiti
media
calv
herd
herd
calv
exclud
morbid
observ
anim
respiratori
includ
calv
treat
respiratori
diseas
alon
respiratori
diseas
conjunct
either
otiti
media
arthriti
otiti
media
includ
calv
treat
otiti
media
alon
otiti
media
conjunct
either
respiratori
diseas
arthriti
mbad
mycoplasma
bovisassoci
diseas
one
control
calf
arthriti
also
respiratori
diseas
b
combin
herd
b
c
analys
perform
data
includ
otiti
media
interact
vaccin
herd
outcom
c
requir
earlier
treatment
respiratori
diseas
day
vaccin
day
control
calv
herd
b
day
vaccin
day
control
vaccin
reduc
overal
bovisassoci
morbid
morbid
specif
associ
otiti
media
respiratori
diseas
fact
vaccin
associ
increas
incid
otiti
media
p
herd
b
differ
incid
otiti
media
group
observ
herd
c
tabl
herd
b
weight
gain
monitor
birth
day
age
signific
differ
observ
averag
daili
gain
group
herd
similarli
signific
differ
observ
averag
daili
gain
vaccin
kgday
n
control
kgday
n
calv
herd
b
endem
bovi
diseas
present
neither
overal
mortal
rate
vaccin
control
bovisassoci
mortal
rate
vaccin
control
differ
significantli
vaccin
control
calv
herd
b
bovisassoci
mortal
contribut
mortal
event
vaccin
control
calv
respect
although
bovisassoci
mortal
also
occur
herd
c
primari
caus
calf
mortal
mortal
vaccin
mortal
control
calv
herd
c
attribut
bovi
nasal
colon
affect
vaccin
herd
b
endem
bovi
diseas
present
mean
percentag
calv
bovisposit
nasal
swab
sampl
time
vaccin
calv
control
calv
averag
number
sampl
time
bovi
recov
calf
also
associ
vaccin
data
shown
irrespect
vaccin
statu
howev
tempor
pattern
colon
fig
observ
calv
herd
mycoplasm
diseas
quit
differ
observ
calv
herd
b
signific
mycoplasm
diseas
calv
herd
minim
nasal
colon
bovi
prewean
period
calv
herd
move
individu
hutch
outdoor
hous
group
lot
sampl
collect
next
sampl
period
week
age
level
nasal
colon
similar
herd
experienc
bovisassoci
diseas
herd
b
calv
bovi
present
nasal
secret
earli
week
age
week
age
calv
colon
upper
respiratori
tract
level
colon
maintain
throughout
sampl
period
serum
antibodi
subclass
respons
subset
calv
herd
b
assess
elisa
fig
signific
differ
vaccin
control
calv
found
either
herd
b
iga
igm
igg
howev
serum
igg
respons
vaccin
detect
signific
differ
p
vaccin
control
group
first
evid
week
age
herd
endem
diseas
week
age
herd
b
endem
diseas
assess
associ
immunoglobulin
subclass
respons
outcom
calv
herd
b
associ
immunoglobulin
subclass
respons
morbid
nasal
colon
rate
data
shown
bovisspecif
serum
igg
titer
week
age
neg
correl
averag
daili
gain
control
calv
r
r
p
vaccin
calv
r
r
p
interestingli
signific
associ
postcolostr
total
serum
protein
concentr
incid
durat
treatment
respiratori
diseas
otiti
media
herd
b
c
data
shown
similarli
incid
bovisspecif
calf
mortal
herd
b
c
associ
postcolostr
total
serum
protein
concentr
data
shown
also
associ
postcolostr
bovisspecif
iga
igm
igg
igg
serum
titer
either
signific
differ
observ
vaccin
control
calv
iga
igm
subclass
vaccin
calv
herd
week
age
herd
b
week
age
significantli
higher
level
p
control
calv
time
point
result
present
mean
optic
densiti
sd
morbid
mortal
intens
studi
subset
calv
n
herd
b
data
shown
commerci
bovi
bacterin
test
trial
efficaci
prevent
either
bovisassoci
respiratori
diseas
otiti
media
prewean
calv
two
florida
herd
endem
bovi
diseas
respons
vaccin
herddepend
higher
rate
otiti
media
associ
vaccin
one
herd
find
uniqu
although
investig
report
protect
bovisassoci
diseas
vaccin
older
calv
advers
outcom
follow
vaccin
bovi
also
report
protect
mycoplasm
respiratori
diseas
subcutan
vaccin
calv
kill
whole
cell
bacterin
report
studi
appar
efficaci
vaccin
young
calv
nichola
et
al
vaccin
dairi
calv
singl
dose
inactiv
saponinadjuvan
bacterin
calv
receiv
aerosol
challeng
live
bovi
week
vaccin
vaccin
calv
fewer
number
bovi
colon
site
fewer
bodi
site
colon
bovi
reduc
sever
incid
clinic
diseas
lesion
compar
control
calv
also
signific
decreas
bodi
weight
gain
control
calv
compar
vaccin
addit
vaccin
calv
two
seven
control
calv
develop
arthriti
vaccin
calv
produc
strong
igg
respons
prior
challeng
igg
subtyp
report
advers
event
associ
vaccin
report
kill
vaccin
four
bovin
respiratori
pathogen
brsv
pi
bovi
dispar
evalu
protect
natur
occur
respiratori
diseas
beef
calv
calv
vaccin
subcutan
receiv
two
booster
interv
one
studi
three
group
beef
calv
age
week
time
first
vaccin
use
calv
follow
month
respiratori
diseas
occur
significantli
higher
p
proport
control
calv
compar
vaccin
second
studi
use
vaccin
protocol
bovi
brsv
implic
outbreak
respiratori
diseas
trial
period
morbid
due
respiratori
diseas
significantli
reduc
vaccin
calv
compar
control
mortal
vaccin
group
similarli
reduc
vaccin
control
respect
advers
effect
vaccin
note
number
key
differ
studi
report
studi
may
influenc
vaccin
efficaci
firstli
strain
bacteria
antigen
concentr
method
bacteri
inactiv
adjuv
use
factor
influenc
efficaci
bacteri
vaccin
although
limit
data
affect
bovi
vaccin
particular
although
data
report
studi
avail
vaccin
eg
adjuv
use
proprietari
like
factor
vari
among
studi
list
secondli
calv
studi
first
vaccin
substanti
older
age
calv
studi
immun
respons
newborn
calf
uniqu
characterist
undergo
rapid
chang
first
week
life
vaccin
day
age
perform
studi
may
elicit
type
immun
respons
vaccin
week
age
nichola
et
al
studi
vaccin
protocol
chosen
base
protocol
appli
dairi
florida
b
earli
age
infect
observ
previou
studi
thirdli
calv
endem
infect
herd
studi
becam
colon
earli
age
mean
infect
like
well
establish
vaccineinduc
immun
respons
could
develop
adapt
immun
respons
develop
infect
ineffici
clear
mycoplasm
infect
often
result
detriment
chronic
inflammatori
respons
could
contribut
vaccin
failur
anim
alreadi
infect
time
vaccin
lastli
challeng
load
bovi
calv
expos
affect
efficaci
vaccin
given
high
incid
clinic
mycoplasm
diseas
calv
treat
bovisassoci
diseas
earli
age
colon
observ
endem
infect
herd
level
bovi
challeng
calv
expos
may
significantli
greater
calv
vaccin
studi
vaccin
calv
one
herd
studi
greater
risk
otiti
media
control
calv
risk
otiti
media
control
calv
herd
b
seem
substanti
less
herd
c
examin
calf
health
record
previou
year
herd
b
show
risk
otiti
media
observ
control
calv
similar
histor
present
data
shown
therefor
vaccin
seem
exacerb
clinic
otiti
media
herd
report
exacerb
clinic
diseas
follow
bovi
vaccin
howev
immun
mechan
associ
advers
outcom
bovi
vaccin
determin
vaccin
calv
stimul
system
humor
immun
respons
increas
serum
igg
detect
third
vaccin
tendenc
toward
igg
domin
humor
respons
also
report
infect
calv
bovi
igg
much
effect
opsonin
phagocytosi
bovi
igg
igg
respons
may
rel
ineffect
control
bovi
respiratori
infect
somewhat
puzzl
humor
respons
infect
obviou
control
calv
herd
b
high
incid
bovisassoci
diseas
statist
comparison
igg
respons
control
group
herd
b
conduct
howev
appear
control
group
herd
postcolostr
igg
antibodi
level
continu
declin
throughout
studi
period
see
fig
wherea
control
group
herd
b
declin
week
age
result
may
reflect
continu
stimul
immun
respons
result
endem
natur
bovi
herd
addit
bovi
infect
result
local
mucos
antibodi
respons
without
elicit
substanti
system
humor
respons
investig
also
note
poor
correl
serum
antibodi
respons
bovi
infect
individu
calv
first
month
life
vaccin
use
studi
ineffect
prevent
upper
respiratori
tract
colon
bovi
calv
even
colon
occur
humor
immun
respons
vaccin
establish
except
one
calf
nasal
colon
detect
calv
herd
week
age
wherea
signific
increas
serum
igg
respons
vaccin
evid
week
age
consist
report
bovi
vaccin
even
bovi
vaccin
associ
clinic
benefit
typic
fail
induc
immun
respons
prevent
upper
respiratori
tract
infect
find
consist
idea
protect
bovi
infect
better
correl
local
mucos
immun
respons
serum
antibodi
titer
total
protein
concentr
bovisspecif
antibodi
level
postcolostr
serum
associ
protect
bovisassoci
diseas
calv
studi
howev
colostrum
pasteur
farm
possibl
colostrum
contain
high
antibodi
concentr
bovi
may
come
cow
intramammari
infect
therefor
may
also
contain
live
bovi
could
certainli
mask
protect
effect
passiv
transfer
assess
herd
level
studi
requir
determin
efficaci
passiv
transfer
prevent
bovisassoci
diseas
control
set
best
author
knowledg
first
peerreview
control
independ
efficaci
studi
bovi
vaccin
avail
north
america
vaccin
efficaci
prevent
bovisassoci
diseas
prewean
calv
two
endem
infect
florida
dairi
herd
effect
prevent
colon
upper
respiratori
tract
older
calv
third
herd
vaccin
stimul
system
igg
respons
detect
third
vaccin
clinic
diseas
occur
prior
respons
calv
endem
infect
herd
colon
bovi
young
age
like
repres
greatest
impedi
success
vaccin
age
group
vaccin
use
field
trial
formul
use
much
older
cattl
stocker
feeder
calv
prevent
respiratori
diseas
result
studi
extrapol
infer
whether
vaccin
efficaci
age
group
find
highlight
import
target
vaccin
use
young
calv
specif
age
group
illustr
challeng
develop
efficaci
vaccin
bovi
use
young
calv
vaccin
age
group
even
possibl
